HFRO vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HFRO exhibits severe financial distress as evidenced by a critical Piotroski F-Score of 1/9, indicating poor operational health. The fund is currently operating as a 'yield trap,' with a dividend payout ratio of 210% that is fundamentally unsustainable and likely eroding the fund's principal. With 0% profit margins and a completely bearish technical trend (0/100), the recent 1-year price recovery appears disconnected from the underlying financial deterioration. The lack of available valuation metrics like the Graham Number further complicates a defensive entry, making the risk-reward profile highly unfavorable.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
HFRO vs JPM: Head-to-Head Comparison
This page compares Highland Funds I - Highland Opportunities and Income Fund (HFRO) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.